Based on current pharmacovigilance and cohort data, several factors appear to increase risk: 1 1 Pre-existing androgenetic alopecia , patients with a genetic predisposition to male or female pattern hair loss, may see it accelerate or become newly noticeable during rapid weight loss
Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus
doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
Pharmacologically, activating ERRs is hypothesized to reproduce elements of endurance training by acutely raising oxidative capacity and fat utilization while remodeling metabolic gene expression across muscle, adipose, and liver
